Cargando…
Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745361/ https://www.ncbi.nlm.nih.gov/pubmed/36523322 http://dx.doi.org/10.21037/tcr-22-709 |
_version_ | 1784849135862546432 |
---|---|
author | Qu, Yuanxu Lu, Jiongdi Mei, Wentong Jia, Yuchen Bian, Chunjing Ding, Yixuan Guo, Yulin Cao, Feng Li, Fei |
author_facet | Qu, Yuanxu Lu, Jiongdi Mei, Wentong Jia, Yuchen Bian, Chunjing Ding, Yixuan Guo, Yulin Cao, Feng Li, Fei |
author_sort | Qu, Yuanxu |
collection | PubMed |
description | BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted to develop a prognostic model for pancreatic cancer based on a competing endogenous RNA (ceRNA) network. METHODS: We obtained transcriptomic data and corresponding clinicopathological information of pancreatic cancer samples from The Cancer Genome Atlas (TCGA) database (training set). Based on the ceRNA interaction network, we screened candidate genes to build prediction models. Univariate Cox regression analysis was performed to screen for genes associated with prognosis, and least absolute shrinkage and selection operator (LASSO) regression analysis was conducted to construct a predictive model. A receiver operating characteristic (ROC) curve was drawn, and the C-index was calculated to evaluate the accuracy of the prediction model. Furthermore, we downloaded transcriptomic data and related clinical information of pancreatic cancer samples from the Gene Expression Omnibus database (validation set) to evaluate the robustness of our prediction model. RESULTS: Eight genes (ANLN, FHDC1, LY6D, SMAD6, ACKR4, RAB27B, AUNIP, and GPRIN3) were used to construct the prediction model, which was confirmed as an independent predictor for evaluating the prognosis of patients with pancreatic cancer through univariate and multivariate Cox regression analysis. By plotting the decision curve, we found that the risk score model is an independent predictor has the greatest impact on survival compared to pathological stage and targeted molecular therapy. CONCLUSIONS: An eight-gene prediction model was constructed for effectively and independently predicting the prognosis of patients with pancreatic cancer. These eight genes identified show potential as diagnostic and therapeutic targets. |
format | Online Article Text |
id | pubmed-9745361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-97453612022-12-14 Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network Qu, Yuanxu Lu, Jiongdi Mei, Wentong Jia, Yuchen Bian, Chunjing Ding, Yixuan Guo, Yulin Cao, Feng Li, Fei Transl Cancer Res Original Article BACKGROUND: Pancreatic cancer is an insidious and heterogeneous malignancy with poor prognosis that is often locally unresectable. Therefore, determining the underlying mechanisms and effective prognostic indicators of pancreatic cancer may help optimize clinical management. This study was conducted to develop a prognostic model for pancreatic cancer based on a competing endogenous RNA (ceRNA) network. METHODS: We obtained transcriptomic data and corresponding clinicopathological information of pancreatic cancer samples from The Cancer Genome Atlas (TCGA) database (training set). Based on the ceRNA interaction network, we screened candidate genes to build prediction models. Univariate Cox regression analysis was performed to screen for genes associated with prognosis, and least absolute shrinkage and selection operator (LASSO) regression analysis was conducted to construct a predictive model. A receiver operating characteristic (ROC) curve was drawn, and the C-index was calculated to evaluate the accuracy of the prediction model. Furthermore, we downloaded transcriptomic data and related clinical information of pancreatic cancer samples from the Gene Expression Omnibus database (validation set) to evaluate the robustness of our prediction model. RESULTS: Eight genes (ANLN, FHDC1, LY6D, SMAD6, ACKR4, RAB27B, AUNIP, and GPRIN3) were used to construct the prediction model, which was confirmed as an independent predictor for evaluating the prognosis of patients with pancreatic cancer through univariate and multivariate Cox regression analysis. By plotting the decision curve, we found that the risk score model is an independent predictor has the greatest impact on survival compared to pathological stage and targeted molecular therapy. CONCLUSIONS: An eight-gene prediction model was constructed for effectively and independently predicting the prognosis of patients with pancreatic cancer. These eight genes identified show potential as diagnostic and therapeutic targets. AME Publishing Company 2022-11 /pmc/articles/PMC9745361/ /pubmed/36523322 http://dx.doi.org/10.21037/tcr-22-709 Text en 2022 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Qu, Yuanxu Lu, Jiongdi Mei, Wentong Jia, Yuchen Bian, Chunjing Ding, Yixuan Guo, Yulin Cao, Feng Li, Fei Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title | Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title_full | Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title_fullStr | Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title_full_unstemmed | Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title_short | Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network |
title_sort | prognostic biomarkers of pancreatic cancer identified based on a competing endogenous rna regulatory network |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745361/ https://www.ncbi.nlm.nih.gov/pubmed/36523322 http://dx.doi.org/10.21037/tcr-22-709 |
work_keys_str_mv | AT quyuanxu prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT lujiongdi prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT meiwentong prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT jiayuchen prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT bianchunjing prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT dingyixuan prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT guoyulin prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT caofeng prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork AT lifei prognosticbiomarkersofpancreaticcanceridentifiedbasedonacompetingendogenousrnaregulatorynetwork |